Neurotransmitter Transporter Uptake Assay Kit from Molecular Devices | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Molecular Devices for
Neurotransmitter Transporter Uptake Assay Kit

Description

The homogeneous Neurotransmitter Transporter Uptake Assay Kit provides a fast, simple, and reliable fluorescence-based assay for the detection of dopamine, norepinephrine, and serotonin transporter (DAT, NET and SERT, respectively) activity in expressing cells, transfected or primary.

Product Specs
ItemNeurotransmitter Transporter Uptake Assay Kit
CompanyMolecular Devices
Price Supplier Page View Company Product Page
Catalog NumberNeurotransmitter Transporter Uptake Assay Kit

Add to Compare List

Molecular Devices

Molecular Devices

3860 N First Street

San Jose, California 95134

United States

Phone: 408-747-1700

Company Profile

Website: www.moleculardevices.com

(1) Structure-Activity Relationships of Dopamine Transporter Pharmacological ChaperonesFrontiers in Cellular NeuroscienceMay 9, 2022Charles Sutton et al.

(2) Development of Dibenzothiazepine Derivatives as Multifunctional Compounds for Neuropathic PainPharmaceuticals (Basel)March 27, 2022Young-Hwan Jung et al.

(3) Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitorsScientific ReportsDecember 1, 2021Hubert J. Sijben, Wieke M. van Oostveen, Peter B. R. Hartog, Laura Stucchi, Andrea Rossignoli, Giovanna Maresca, Lia Scarabottolo, Adriaan P. IJzerman, Laura H. Heitman

(4) Prediction of pharmacological activities from chemical structures with graph convolutional neural networksScientific ReportsDecember 1, 2021Miyuki Sakai, Kazuki Nagayasu, Norihiro Shibui, Chihiro Andoh, Kaito Takayama, Hisashi Shirakawa, Shuji Kaneko

(5) The chemical tools for imaging dopamine releaseCell Chemical BiologyJune 1, 2021Michael R. Post, David Sulzer

(6) Topical application of Zanthoxylum piperitum extract improves lateral canthal rhytides by inhibiting muscle contractionsScientific ReportsDecember 9, 2020Wooseon Hwang, Daehyun Kim, Oh Sun Kwon, Yun-Sun Kim, Byungjun Ahn, Nae-Gyu Kang

(7) Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depressionScientific reportsJune 8, 2020Brimson JM, Akula KK, Abbas H, Ferry DR, Kulkarni SK, Russell ST, Tisdale MJ, Tencomnao T, Safrany ST.

(8) Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gutNature MicrobiologyDecember 1, 2019Thomas C. Fung et al.

(9) Pharmacokinetic-Pharmacodynamic Modeling of Brain Dopamine Levels Based on Dopamine Transporter Occupancy after Administration of Methylphenidate in RatsJournal of Pharmacology and Experimental TherapeuticsApril 1, 2019Ryosuke Shimizu, Naotaka Horiguchi, Koji Yano, Masashi Sakuramoto, Naoki Kanegawa, Shunji Shinohara, Shuichi Ohnishi

(10) Discovery of a Potent, Selective, and Brain-Penetrant Small Molecule that Activates the Orphan Receptor GPR88 and Reduces Alcohol IntakeJournal of medicinal chemistryAugust 9, 2018Jin C, Decker AM, Makhijani VH, Besheer J, Darcq E, Kieffer BL, Maitra R.

(11) The Development of Screening Methods to Identify Drugs to Limit ER Stress Using Wild-type and Mutant Serotonin TransporterActa Histochemica et CytochemicaDecember 28, 2016Kazusa Katarao, Seiya Murakawa, Masaya Asano, Naoto Usuki, Hikaru Yamamoto, Toshihiko Shirafuji, Shigeru Tanaka, Izumi Hide, Norio Sakai

(12) Functional constituents of a local serotonergic system, intrinsic to the human coronary artery smooth muscle cellsMolecular biology reportsAugust 1, 2015Baskar K, Sur S, Selvaraj V, Agrawal DK.

(13) Ketamine Causes Mitochondrial Dysfunction in Human Induced Pluripotent Stem Cell-Derived NeuronsPLOS ONEMay 28, 2015Hiroyuki Ito, Tokujiro Uchida, Koshi Makita

(14) Exploration of 3-Aminoazetidines as Triple Reuptake Inhibitors by Bioisosteric Modification of 3-α-OxyazetidineACS Medicinal Chemistry LettersSeptember 11, 2014Minsoo Han, Chiman Song, Nakcheol Jeong, Hoh-Gyu Hahn

(15) N-ethylmaleimide-sensitive factor interacts with the serotonin transporter and modulates its trafficking: implications for pathophysiology in autismMolecular autismJanuary 1, 2014Iwata K, Matsuzaki H, Tachibana T, Ohno K, Yoshimura S, Takamura H, Yamada K, Matsuzaki S, Nakamura K, Tsuchiya KJ, et al.

(16) New fluorescent substrate enables quantitative and high-throughput examination of vesicular monoamine transporter 2 (VMAT2)ACS chemical biologySeptember 20, 2013Hu G, Henke A, Karpowicz RJ Jr, Sonders MS, Farrimond F, Edwards R, Sulzer D, Sames D.

(17) Selective κ Opioid Antagonists nor-BNI, GNTI and JDTic Have Low Affinities for Non-Opioid Receptors and TransportersPLoS ONEAugust 14, 2013Thomas A. Munro et al.

(18) APP+, a Fluorescent Analogue of the Neurotoxin MPP+, Is a Marker of Catecholamine Neurons in Brain Tissue, but Not a Fluorescent False NeurotransmitterACS Chemical NeuroscienceMay 15, 2013Richard J. Karpowicz, Matthew Dunn, David Sulzer, Dalibor Sames

(19) Distinct Modes of Dopamine and GABA Release in a Dual Transmitter NeuronJournal of NeuroscienceJanuary 30, 2013Maria Borisovska, AeSoon L Bensen, Gene Chong, Gary L. Westbrook

(20) The Design and Synthesis of 1,4-Substituted Piperazine Derivatives as Triple Reuptake InhibitorsBulletin of the Korean Chemical SocietyAugust 20, 2012Min-Soo Han, Young-Hue Han, Chi-Man Song, Hoh-Gyu Hahn

Be the First to Write a Review!